Dr. Hugo Yeo-Chiao Hsu, MD

Dr. Hsu practices at Southern California Permanente Medical Group in Los Angeles, California.

Dr. Hsu's NPI, 1336153816, was assigned on July 28, 2006. Dr. Hsu graduated from David Geffen School of Medicine at UCLA in 1999. Dr. Hsu holds California license A74891.

Dr. Hsu's primary practice is Southern California Permanente Medical Group, at 4760 W Sunset Blvd, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (323) 783-4011.

Dr. Hsu's primary practice is Southern California Permanente Medical Group in Los Angeles, California. Dr. Hsu is also affiliated with Kaiser Permanente Los Angeles Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Hsu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hsu practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Hsu's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Hsu is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Hsu's licenses on file in 3 states: California, Missouri and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Hsu treats.

CMS data shows 2,191 Medicare services from Dr. Hsu across 17 procedure codes in 2024, for 813 Medicare patients. Medicare paid $200,989 for them.

CMS counts 813 Medicare patients who saw Dr. Hsu in 2024. The largest group is 75 to 84, with 349 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hsu's median patient age at 72, with 64% women.

In 2024, Dr. Hsu wrote 2,152 Medicare Part D claims for 413 patients. 53% of them were for generic drugs. CMS names the drug for 1,986 of them, across 25 drugs with 11 or more claims each, at $191,450 in total drug cost. In 2023, CMS named 2,149 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Hsu for performance year 2024, reported as part of a group. Dr. Hsu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Dr. Hsu, published from 2009 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Cornea, Visual Acuity and Conjunctiva. Dr. Hsu has published most often in Cornea. Dr. Hsu's most frequent co-authors are Sean Lewis Edelstein, MD, Srinivas Reddy Sadda, MD and John Thompson Lind, MD.

CMS Open Payments shows 22 general payments to Dr. Hsu from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Alcon Laboratories Inc paid the most, $253.

Dmand AI lists 1 award for Dr. Hsu.

Dr. Hsu graduated from David Geffen School of Medicine at UCLA in 1999. Dr. Hsu is a member of AAO.

Dr. Hsu is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.